Literature DB >> 15820768

The mechanisms of differential glucocorticoid and mineralocorticoid action in the brain and peripheral tissues.

Shirya Rashid1, Gary F Lewis.   

Abstract

Mineralocorticoids and glucocorticoids are key categories of adrenocorticosteroid hormones that mediate distinct physiological responses. While the primary role of aldosterone, the major mineralocorticoid, is in regulating sodium homeostasis, the major role of the glucocorticoids is mediating the catabolic response to stress. Over the past two decades, these adrenocorticosteroid hormones have been the subject of considerable attention due to the paradox that despite exerting greatly different physiological effects, they act through very closely related receptors and a common DNA response element. This review will examine the research focused on the mechanisms of selective adrenocorticosteroid action. In general, it has been demonstrated that differential adrenocorticosteroid action is mediated at pre-receptor, receptor, and post-receptor levels, depending on the target tissue and physiological environment. The marked neuroendocrine pathophysiologies resulting from perturbations in this complex system make it imperative that further research into mechanisms of coordination of the three levels of adrenocorticosteroid control be conducted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15820768     DOI: 10.1016/j.clinbiochem.2004.11.009

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  11 in total

1.  Cyclin-dependent kinase 5 modulates the transcriptional activity of the mineralocorticoid receptor and regulates expression of brain-derived neurotrophic factor.

Authors:  Tomoshige Kino; Howard Jaffe; Niranjana D Amin; Mayukh Chakrabarti; Ya-Li Zheng; George P Chrousos; Harish C Pant
Journal:  Mol Endocrinol       Date:  2010-03-31

2.  Chronic blockade of hindbrain glucocorticoid receptors reduces blood pressure responses to novel stress and attenuates adaptation to repeated stress.

Authors:  Andrea G Bechtold; Gina Patel; Guenther Hochhaus; Deborah A Scheuer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-03-11       Impact factor: 3.619

3.  Glucocorticoid receptor changes associate with age in the paraventricular nucleus of type II diabetic rat model.

Authors:  Sun Shin Yi; In Koo Hwang; Myung Sun Chun; Yo Na Kim; Il Yong Kim; In Se Lee; Je Kyung Seong; Yeo Sung Yoon
Journal:  Neurochem Res       Date:  2008-08-29       Impact factor: 3.996

Review 4.  Pain and stress in a systems perspective: reciprocal neural, endocrine, and immune interactions.

Authors:  C Richard Chapman; Robert P Tuckett; Chan Woo Song
Journal:  J Pain       Date:  2007-12-21       Impact factor: 5.820

5.  Cortisol stimulates proliferation and apoptosis in the late gestation fetal heart: differential effects of mineralocorticoid and glucocorticoid receptors.

Authors:  Xiaodi Feng; Seth A Reini; Elaine Richards; Charles E Wood; Maureen Keller-Wood
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-06-19       Impact factor: 3.619

6.  The organisation of the stress response, and its relevance to chiropractors: a commentary.

Authors:  Katie Hardy; Henry Pollard
Journal:  Chiropr Osteopat       Date:  2006-10-18

7.  Sequential alterations of glucocorticoid receptors in the hippocampus of STZ-treated type 1 diabetic rats.

Authors:  Jae Hoon Shin; Je Kyung Seong; Sun Shin Yi
Journal:  J Vet Sci       Date:  2013-06-30       Impact factor: 1.672

8.  Glucocorticoid receptor, but not mineralocorticoid receptor, mediates cortisol regulation of epidermal ionocyte development and ion transport in zebrafish (danio rerio).

Authors:  Shelly Abad Cruz; Chia-Hao Lin; Pei-Lin Chao; Pung-Pung Hwang
Journal:  PLoS One       Date:  2013-10-29       Impact factor: 3.240

Review 9.  Evidence for adverse effect of perinatal glucocorticoid use on the developing brain.

Authors:  Young Pyo Chang
Journal:  Korean J Pediatr       Date:  2014-03-31

10.  Repurposing existing drugs for COVID-19: an endocrinology perspective.

Authors:  Flavio A Cadegiani
Journal:  BMC Endocr Disord       Date:  2020-09-29       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.